Cushing Disease

21 registered clinical trials studyying Cushing Disease — 10 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease NCT07460232	Mayo Clinic	EARLY_Phase 1
Enrolling By Invitation	Use of [18F]FET PET-MRI to Improve Detection of Pituitary Adenomas in Cushing's Disease NCT07108244	University Hospital, Basel, Switzerland	N/A
Recruiting	Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease NCT05971758	University of California, Los Angeles	Phase 2
Recruiting	Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushi NCT07335315	Mayo Clinic	—
Recruiting	Evaluation of Positron Emission Tomography (PET) With [18F]FET for the Detection of ACTH-Secreting Corticotrop NCT07463625	Hospices Civils de Lyon	—
Recruiting	A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome NCT05804669	Crinetics Pharmaceuticals Inc.	Phase 1 / Phase 2
Completed	Hair Cortisol and Cushing's Disease NCT04201444	University Hospital, Bordeaux	N/A
Active Not Recruiting	Postoperative Thrombosis Prevention in Patients With CD NCT04486859	Huashan Hospital	N/A
Active Not Recruiting	Discriminant Capacity and Thresholds of Salivary Cortisol in Chemiluminescence in the Diagnosis of Hypercortic NCT03974789	Centre Hospitalier Universitaire de Nīmes	—
Recruiting	Long-Term Follow-Up of Survivors of Pediatric Cushing Disease NCT03831958	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	—
Completed	Open-label Treatment in Cushing's Syndrome NCT03621280	Cortendo AB	Phase 3
Recruiting	Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease NCT03774446	Cedars-Sinai Medical Center	Phase 2
Unknown	Clinical Study on Circadian Genes Dysregulation in Patients With Glucocorticoid Disorders NCT04374721	University of Roma La Sapienza	N/A
Recruiting	Collecting Information About Treatment Results for Patients With Cushing's Syndrome NCT03364803	Memorial Sloan Kettering Cancer Center	—
Unknown	Health Status of the Patients Followed for a Disease of Cushing in the Region Large-West of 1990 to 2015 NCT03297892	University Hospital, Brest	—
Completed	Cushing´s Disease Epidemiology in Sweden NCT02350153	Vastra Gotaland Region	—
Completed	The Factors Associated With the Recurrence in Patients With Cushing Disease NCT02233335	National Taiwan University Hospital	—
Completed	Adipokine Profile in Patients With Cushing's Disease on Pasireotide Treatment NCT03080181	University of Palermo	Phase 4
Completed	Safety and Efficacy of LCI699 in Cushing's Disease Patients NCT01331239	Novartis Pharmaceuticals	Phase 2
Completed	Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's Disease NCT00171951	Novartis Pharmaceuticals	Phase 2
Recruiting	An Investigation of Pituitary Tumors and Related Hypothalmic Disorders NCT00001595	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	—